NonprofitsScleroderma Clinical Trials Consortium Inc

Medical Research

Scleroderma Clinical Trials Consortium Inc

BOSTON, MA

Total revenue

$326K

Total expenses

$299K

Net assets

$4.0M

Grants received

EIN

043543489

Tax year

2024

Mission

To foster scientific research and to advance medical research in the form of treatment trials in scleroderma on a worldwide basis.

Financials

FY 2024

Revenue

Contributions & grants$217K
Program service revenue
Investment income$109K
Other revenue
Total revenue$326K

Expenses

Grants paid$222K
Salaries & benefits
Fundraising
Other expenses$76K
Total expenses$299K
Total assets$4.0M
Net assets$4.0M

People

4 listed

NameRoleCompensation

ROBYN THERESE DOMSIC-DEGAZIO

PRESIDENT

Board

TRACY FRENCH

VICE PRESIDE

Board

JERRY A MOLITOR

TREASURER

Board

VANESSA SMITH

SECRETARY

Board

Details

EIN043543489
NTEE codeH99
Subsection03
Ruling date2001-06
Formed2001
Employees0
SCLERODERMA CLINICAL TRIALS CONSORTIUM INC — Mission, Financials & Grants Received | Grantivo